Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

  1. Capdevila, J.
  2. Trigo, J.M.
  3. Aller, J.
  4. Manzano, J.L.
  5. Adrián, S.G.
  6. Llopis, C.Z.
  7. Reig, Ò.
  8. Bohn, U.
  9. Cajal, T.R.Y.
  10. Duran-Poveda, M.
  11. Astorga, B.G.
  12. López-Alfonso, A.
  13. Martínez, J.M.
  14. Porras, I.
  15. Reina, J.J.
  16. Palacios, N.
  17. Grande, E.
  18. Cillán, E.
  19. Matos, I.
  20. Grau, J.J.
Aldizkaria:
European Journal of Endocrinology

ISSN: 1479-683X,  0804-4643

Argitalpen urtea: 2017

Alea: 177

Zenbakia: 4

Orrialdeak: 309-317

Mota: Artikulua

DOI: 10.1530/EJE-17-0243 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus